
pmid: 702755
RIFAMPIN is a potent antibiotic with the capacity for serious and unusual side effects, even in therapeutic dosages. 1,2 Deaths in patients taking therapeutic dosages have been attributed to an unknown immunologic mechanism and have occurred almost exclusively in patients taking the drug at irregular intervals. 3 Massive overdose, "the red man syndrome," has been reported in one patient whose clinical course was uneventful. 4 We report the first case, to our knowledge, of rifampin overdose resulting in death after deliberate ingestion. Report of a Case A 26-year-old mentally retarded man had been well until 24 hours before admission, when considerable nausea, vomiting, and diffuse abdominal pain developed. He took magnesium sulfate with symptomatic improvement. However, within two hours of the onset of symptoms, an intense generalized pruritus developed. During the next 30 minutes, a faint, orange discoloration of the skin became apparent, and he was brought to the emergency
Adult, Male, Suicide, Intellectual Disability, Color, Humans, Diagnostic Errors, Rifampin, Skin
Adult, Male, Suicide, Intellectual Disability, Color, Humans, Diagnostic Errors, Rifampin, Skin
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 23 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
